CTL/NN
recognition/NN
of/IN
an/DT
altered/JJ
peptide/NN
associated/VBN
with/IN
asparagine/NN
bond/NN
rearrangement/NN
./.
=====
Implications/NNS
for/IN
immunity/NN
and/CC
vaccine/NN
design/NN
./.

The/DT
extent/NN
to/TO
which/WDT
peptides/NNS
containing/VBG
chemically/RB
and/CC
post-translationally/RB
modified/VBN
amino/NN
acid/NN
side/JJ
chains/NNS
are/VBP
recognized/VBN
by/IN
primed/JJ
CTL/NN
has/VBZ
not/RB
been/VBN
clearly/RB
defined/VBN
./.
=====
We/PRP
report/VBP
on/IN
the/DT
CTL/NN
recognition/NN
of/IN
a/DT
MHC/NN
class/NN
I-restricted/JJ
peptide/NN
containing/VBG
a/DT
cyclized/JJ
asparagine/NN
(/(
succinimide/NN
)/)
residue/NN
./.
=====
This/DT
modification/NN
of/IN
the/DT
asparagine/NN
side/JJ
chain/NN
is/VBZ
a/DT
common/JJ
intermediate/JJ
structure/NN
during/IN
deamidation/NN
,/,
isomerization/NN
,/,
and/CC
bond/NN
rearrangements/NNS
of/IN
amide-containing/JJ
amino/NN
acids/NNS
and/CC
also/RB
occurs/VBZ
as/IN
a/DT
side/JJ
reaction/NN
in/IN
peptide/NN
synthesis/NN
./.
=====
The/DT
CTL/NN
specifically/RB
recognized/VBD
the/DT
succinimide-containing/JJ
peptide/NN
showing/VBG
only/RB
weak/JJ
cross-reactivity/NN
at/IN
high/JJ
concentrations/NNS
of/IN
the/DT
parent/NN
peptide/NN
containing/VBG
unmodified/JJ
asparagine/NN
./.
=====
Similarly/RB
,/,
CTL/NN
raised/VBN
against/IN
the/DT
parent/NN
peptide/NN
did/VBD
not/RB
recognize/VB
the/DT
succinimide/JJ
derivative/NN
of/IN
this/DT
peptide/NN
./.
=====
Naturally/RB
processed/VBN
forms/NNS
of/IN
these/DT
structures/NNS
are/VBP
likely/JJ
to/TO
occur/VB
given/VBN
the/DT
importance/NN
and/CC
frequency/NN
of/IN
deamidation/NN
both/CC
in/FW
vitro/FW
and/CC
in/FW
vivo/FW
./.
=====
Moreover/RB
,/,
since/IN
succinimide/NN
intermediates/NNS
of/IN
deamidated/VBN
peptides/NNS
can/MD
occasionally/RB
be/VB
very/RB
stable/JJ
,/,
these/DT
peptides/NNS
have/VBP
the/DT
potential/NN
to/TO
act/VB
as/IN
altered/JJ
self-Ags/NNS
with/IN
significant/JJ
implications/NNS
for/IN
autoimmunity/NN
./.
=====
In/IN
addition/NN
,/,
unwanted/JJ
and/CC
potentially/RB
hazardous/JJ
specificities/NNS
may/MD
be/VB
elicited/VBN
when/WRB
using/VBG
synthetic/JJ
peptides/NNS
in/IN
subunit/NN
vaccines/NNS
in/IN
which/WDT
succinimide/NN
residues/NNS
may/MD
form/VB
spontaneously/RB
during/IN
storage/NN
or/CC
chemical/JJ
synthesis/NN
./.